Insider Trading Activity For Repro-Med Systems, Inc. (NASDAQ:REPR)
Joseph M Jr. Manko , Director of Repro-Med Systems, Inc. (NASDAQ:REPR) reportedly Bought 22,500 shares of the company’s stock at an average price of 0.43 for a total transaction amount of $9,675.00 SEC Form
Analyst Ratings For Repro-Med Systems, Inc. (NASDAQ:REPR)
These are No ratings tracked in the last 12 months.The current consensus rating for Repro-Med Systems, Inc. (NASDAQ:REPR) is N/A (Score: NaN) with a consensus target price of N/A
About Repro-Med Systems, Inc. (NASDAQ:REPR)
REPRO MED SYSTEMS, INC. (RMS) designs, manufactures and markets medical devices for the ambulatory infusion market and emergency medical applications. The Company’s products include FREEDOM60 Syringe Infusion System (FREEDOM60), RMS HIGH-Flo Subcutaneous Safety Needle Sets (HIgH-Flo), RES-Q-VAC Portable Medical Suction System (RES-Q-VAC) and On-Line Calculator. The FREEDOM60 consists of the FREEDOM60 Syringe Infusion Pump and RMS Precision Flow Rate Tubing. The HIgH-Flo is designed for self-administration of medicine under the skin. The RES-Q-VAC is a hand-operated suction device that removes fluids from a patient’s airway by attaching the RES-Q-VAC pump to various sterile and non-sterile single-use catheters sized for adult and pediatric suctioning. The On-Line Calculator is a tool to help determine which of the Company’s Precision Flow Rate Tubing and RMS HIgH-Flo Subcutaneous Needle Sets are to be used based on the medication being administered and time of infusion.
Recent Trading Activity for Repro-Med Systems, Inc. (NASDAQ:REPR)
Shares of Repro-Med Systems, Inc. closed the previous trading session at 0.421 down -0.019 -4.32% with 23,400 shares trading hands.
Latest posts by ME Staff (see all)
- Analyst Activity – Stephens Initiates Coverage On Energy Recovery (NASDAQ:ERII) With a Overweight - January 11, 2017
- Analyst Activity – Jefferies Group Reiterates Buy on Enova International (NYSE:ENVA) - January 11, 2017
- Analyst Upgrades – eHealth (NASDAQ:EHTH) Stock Gets Upgraded By Craig Hallum from Hold to Buy - January 11, 2017